Parnassus Investments
EW icon

Parnassus Investments’s Edwards Lifesciences EW Stock Holding History

Parnassus Investments’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$91.9M Buy
1,015,630
+20,458
+2% +$1.71M 0.25% 60
2026
Q1 		$79.7M Buy
995,172
+408,412
+70% +$33.7M 0.23% 63
2025
Q4 		$50M Buy
586,760
+111,843
+24% +$9.18M 0.13% 88
2025
Q3 		$36.9M Buy
+474,917
New +$37.1M 0.09% 102
2013
Q4 		– Sell
-900,000
Closed -$10.4M – 117
2013
Q3 		$10.4M Buy
+900,000
New +$10.5M 0.12% 85

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Parnassus Investments's EW Position: Q2 2026 in Review

Parnassus Investments increased its Edwards Lifesciences (EW) stake by 2.1% in Q2 2026, buying an estimated $1.71M and bringing the position to 1,015,630 shares worth $91.9M. The position accounts for 0.25% of the portfolio, ranked #60.

Parnassus Investments first reported a position in EW in Q3 2013 and has held it in 5 quarters since. 1,330 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Parnassus Investments held 1,015,630 shares of Edwards Lifesciences worth $91.9M as of Q2 2026.
  • Parnassus Investments bought 20,458 Edwards Lifesciences shares in Q2 2026, an estimated $1.71M.
  • Edwards Lifesciences made up 0.25% of Parnassus Investments's portfolio in Q2 2026, its #60 holding.
  • Parnassus Investments first reported a position in Edwards Lifesciences in Q3 2013 and has held it in 5 quarters since.
  • 1,330 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Parnassus Investments's 13F filing for Q2 2026, filed 29 Jul 2026.